BioHarvest Competitors

OTC Stocks . USA . 
Stock . BioHarvest Sciences Common
BHST Stock   5.19  0.12  2.37%   
BioHarvest Sciences competes with Lavoro Limited, American Vanguard, Bioceres Crop, Friedman Industries, and US GoldMining; as well as few others. Analyzing BioHarvest Sciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of BioHarvest Sciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in real.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of BioHarvest Sciences competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioHarvest Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

BioHarvest Sciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between BioHarvest Sciences and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of BioHarvest and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of BioHarvest Sciences does not affect the price movement of the other competitor.

High positive correlations

AVD
+ 0.93
LVRO
MERC
+ 0.9
USGO
USGO
+ 0.79
LVRO
USGO
+ 0.75
AVD
ACNT
+ 0.74
CMT
FF
+ 0.73
USGO
  

High negative correlations

ACNT
- 0.82
FF
ACNT
- 0.66
LVRO
ACNT
- 0.59
USGO
TRX
- 0.57
BIOX
ACNT
- 0.57
AVD
ACNT
- 0.52
BIOX

Risk-Adjusted Indicators

There is a big difference between BioHarvest OTC Stock performing well and BioHarvest Sciences OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioHarvest Sciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LVRO  3.61 (1.79) 0.00  1.24  0.00 
 0.00 
 6.45 
(13.25)
 26.41 
AVD  2.33 (0.58) 0.00  3.72  0.00 
 0.00 
 3.39 
(6.33)
 13.30 
BIOX  4.85  0.01  0.00  0.03  0.00 
 0.00 
 10.92 
(8.37)
 38.99 
FRD  2.28 (0.03)(0.01)(0.01) 3.46 
(2.19)
 5.32 
(5.83)
 16.33 
USGO  2.75 (0.56) 0.00 (0.34) 0.00 
 0.00 
 5.21 
(6.74)
 17.51 
FF  2.17 (0.31) 0.00 (0.30) 0.00 
 0.00 
 3.37 
(4.98)
 25.34 
CMT  1.86 (0.10) 0.00 (0.85) 0.00 
 0.00 
 3.18 
(4.79)
 10.19 
TRX  4.22  0.67  0.14  0.39  4.41 
(5.29)
 9.21 
(8.47)
 37.42 
MERC  3.23 (0.43) 0.00 (0.35) 0.00 
 0.00 
 6.00 
(6.78)
 20.33 
ACNT  1.55  0.39  0.25  0.88  1.07 
(2.04)
 4.58 
(2.18)
 10.64 
All Fundamental Data

BioHarvest Sciences Competitive Analysis

The better you understand BioHarvest Sciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, BioHarvest Sciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across BioHarvest Sciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BHST LVRO AVD BIOX FRD USGO FF CMT TRX MERC
 2.37 
 5.19 
BioHarvest
 6.25 
 0.45 
Lavoro
 1.04 
 3.82 
American
 0.77 
 1.31 
Bioceres
 2.06 
 20.49 
Friedman
 2.00 
 8.82 
USGO
 1.85 
 3.19 
FutureFuel
 0.55 
 20.05 
Core
 2.13 
 0.92 
Tanzanian
 1.98 
 1.98 
Mercer
Market Volatility
(90 Days Market Risk)
Unknown risk
Abnormally volatile
Slightly risky
Extremely Dangerous
Not too volatile
Not too volatile
Slightly risky
Very steady
Extremely Dangerous
Very risky
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Weak
Weakest
Weakest
Weakest
Soft
Fair
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
High
Small
Small
Low
Strong
Low
Low
Tiny
Small
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Strong Buy
Strong Buy
Not Available
Buy
Not Available
Buy
Not Available
Hold
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Sell
Cautious Hold
Strong Sell
Hold
Strong Sell
Current Ratio
N/A
1.88
1.34
3.78
N/A
4.16
1.42
1.45
3.39
Net Asset
8.35 B
636.72 M
763.65 M
226.82 M
5.15 M
247.69 M
209.55 M
117.25 M
2.26 B
Profit Margin
-0.1
-0.21
-0.18
0.0224
N/A
-0.25
0.0309
0.0119
-0.0905
EBITDA
411.68 M
(9.43 M)
13.59 M
13.94 M
(8.34 M)
25.64 M
30.97 M
18.7 M
15.01 M
Operating Margin
0.0017
-0.0437
0.0892
0.22
N/A
-0.43
0.0456
0.31
-0.15
Current Valuation
300.46 M
293.11 M
324.36 M
235.13 M
116.26 M
6.43 M
150.36 M
263.73 M
1.61 B
Price To Book
0.38
0.49
0.32
1.06
31.03
0.83
1.11
4.63
0.37
Retained Earnings
(1.02 B)
204.88 M
(65.04 M)
101.25 M
(23.2 M)
383 K
135.37 M
(121.21 M)
230.91 M
Current Asset
N/A
236.83 M
102.35 M
49.7 M
N/A
359.82 M
62.68 M
787 K
429.36 M
Five Year Return
N/A
0.43
N/A
1.4
N/A
2.2
N/A
N/A
3.48
Beta
0.46
1.21
0.45
1.56
2.16
0.85
0.52
0.62
0.76
Number Of Employees
3.77 K
755
751
271
6
537
1.57 K
241
3.58 K
Shares Outstanding
114.59 M
28.47 M
63.48 M
7.11 M
13.27 M
43.8 M
8.56 M
286.96 M
66.98 M
Cash Flow From Operations
165.75 M
3.92 M
49.91 M
(4.41 M)
(7.75 M)
24.8 M
35.15 M
16.28 M
90.2 M
Annual Yield
N/A
N/A
N/A
0.0076
N/A
0.0752
N/A
N/A
0.16
Total Debt
1.85 B
167.81 M
276.61 M
50.48 M
109.39 K
41.87 M
23.7 M
2.81 M
1.49 B
Return On Equity
-0.62
-0.41
-0.19
0.0855
-1.45
-0.18
0.0532
1.22
-0.39
Return On Asset
0.0025
-0.0162
-0.0039
0.0312
-0.77
-0.11
0.0434
0.1
-0.0175
Number Of Shares Shorted
44.81 K
709.58 K
1.23 M
114.76 K
114.95 K
425.88 K
177.21 K
3.79 M
2.74 M
Book Value Per Share
1.35
7.61
4.08
19.73
0.3
3.86
18.16
0.2
5.38
Current Liabilities
N/A
76.28 M
111.06 M
2.87 M
N/A
48.55 M
31.15 M
9.81 M
119.22 M
Total Asset
8.35 B
636.72 M
763.65 M
226.82 M
5.15 M
247.69 M
209.55 M
117.25 M
2.26 B
Short Ratio
2.99
3.69
3.25
4.77
3.19
1.97
7.63
2.55
3.96
Target Price
1.88
12.0
2.25
N/A
35.0
14.0
22.0
1.58
1.94
Debt To Equity
N/A
0.33
1.07
1.01
N/A
0.001
0.33
0.24
1.89
Last Dividend Paid
N/A
0.03
N/A
0.16
N/A
0.24
N/A
N/A
0.23
Shares Owned By Institutions
86.34
69.62
31.17
60.08
6.08
39.5
78.92
2.48
48.72
Market Capitalization
60.75 M
109.89 M
82.52 M
148.79 M
117.07 M
139.73 M
172.6 M
269.73 M
135.3 M
Price To Earning
N/A
44.2
513.33
3.63
N/A
7.95
11.19
-4.03
3.05
Price To Earnings To Growth
N/A
2.27
1.95
N/A
N/A
N/A
N/A
N/A
1.54
Price To Sales
0.0062
0.21
0.26
0.29
N/A
1.02
0.66
4.7
0.071
Net Income
(810.62 M)
(126.34 M)
(58.85 M)
6.08 M
(8.49 M)
15.5 M
13.3 M
6.57 M
(85.14 M)
Earnings Per Share
-1.51
-3.98
-0.89
1.63
-0.53
-0.79
0.93
0.0021
-2.57
Shares Owned By Insiders
10.16
8.54
35.75
6.24
78.52
42.36
9.15
0.74
65.59
Revenue
9.39 B
547.31 M
333.3 M
444.6 M
N/A
243.34 M
302.38 M
57.61 M
2.04 B
Working Capital
(158.06 M)
146.54 M
(29.67 M)
128.14 M
3.7 M
131.48 M
66.18 M
1.31 M
653.47 M
Cash And Equivalents
N/A
12.51 M
38.61 M
2.41 M
N/A
109.54 M
41.8 M
10.46 M
362.25 M
Cash Per Share
N/A
0.71
0.84
0.33
N/A
3.85
0.01
0.04
5.48
Gross Profit
1.37 B
127.8 M
125.43 M
62.36 M
N/A
(24.56 M)
46.13 M
27.73 M
211.82 M
Day Typical Price
5.21
0.37
3.83
1.3
20.49
8.9
3.2
20.16
0.93
2.0
Accumulation Distribution
1435.78
29013.36
4239.14
6371.95
0.0102
0.0659
0.0185
2094.69
0.0421
8209.24
Market Facilitation Index
0.0
0.0
N/A
N/A
0.21
0.61
0.06
0.0
0.04
N/A
Daily Balance Of Power
0.4615
(0.11)
(0.44)
0.1667
(2.05)
(0.30)
(1.00)
(0.12)
(0.50)
(0.80)
Period Momentum Indicator
0.12
(0.03)
(0.04)
0.01
(0.43)
(0.18)
(0.06)
(0.11)
(0.02)
(0.04)
Rate Of Daily Change
1.02
0.94
0.99
1.01
0.98
0.98
0.98
0.99
0.98
0.98
Day Median Price
5.22
0.33
3.84
1.3
20.5
8.95
3.21
20.22
0.93
2.01
Price Action Indicator
0.03
0.11
(0.04)
0.015
(0.22)
(0.21)
(0.05)
(0.22)
(0.02)
(0.04)
Relative Strength Index
35.38
24.46
35.34
45.27
58.23
43.87
49.33
65.97
64.34
47.19
Coefficient Of Variation
(664.25)
(267.85)
(508.49)
(92,041)
53440.61
(741.95)
(1,291)
(2,872)
763.91
(1,188)
Mean Deviation
4.72
3.61
2.33
4.85
2.28
2.75
2.17
1.86
4.22
3.23
Jensen Alpha
(0.95)
(1.79)
(0.58)
0.0098
(0.03)
(0.56)
(0.31)
(0.1)
0.6716
(0.43)
Total Risk Alpha
(1.41)
(2.20)
(0.79)
(0.48)
(0.23)
(0.74)
(0.50)
(0.26)
0.3587
(0.67)
Sortino Ratio
N/A
N/A
N/A
N/A
(0.01)
N/A
N/A
N/A
0.1356
N/A
Downside Variance
N/A
N/A
N/A
N/A
13.33
N/A
N/A
N/A
28.16
N/A
Standard Deviation
6.36
4.95
2.92
6.71
3.23
3.56
3.32
2.36
5.94
4.32
Kurtosis
1.1
1.24
(0.16)
4.3
1.33
0.1912
6.79
(0.03)
5.52
1.4
Potential Upside
13.22
6.45
3.39
10.92
5.32
5.21
3.37
3.18
9.21
6.0
Treynor Ratio
2.45
1.24
3.72
0.031
(0.01)
(0.34)
(0.30)
(0.85)
0.3876
(0.35)
Maximum Drawdown
30.0
26.41
13.3
38.99
16.33
17.51
25.34
10.19
37.42
20.33
Variance
40.5
24.54
8.55
45.05
10.45
12.71
11.06
5.59
35.31
18.67
Market Risk Adjusted Performance
2.46
1.25
3.73
0.041
0.0019
(0.33)
(0.29)
(0.84)
0.3976
(0.34)
Risk Adjusted Performance
(0.1)
(0.25)
(0.13)
0.0082
0.0091
(0.09)
(0.05)
(0.02)
0.1012
(0.05)
Skewness
1.09
(0.29)
(0.36)
1.58
(0.31)
(0.20)
0.887
(0.43)
1.37
0.3962
Semi Deviation
N/A
N/A
N/A
N/A
3.46
N/A
N/A
N/A
4.41
N/A
Information Ratio
(0.16)
(0.39)
(0.22)
(0.01)
(0.02)
(0.15)
(0.1)
(0.06)
0.121
(0.1)
Value At Risk
(8.94)
(13.25)
(6.33)
(8.37)
(5.83)
(6.74)
(4.98)
(4.79)
(8.47)
(6.78)
Expected Short fall
N/A
N/A
N/A
N/A
(2.19)
N/A
N/A
N/A
(5.29)
N/A
Downside Deviation
N/A
N/A
N/A
N/A
3.65
N/A
N/A
N/A
5.31
N/A
Semi Variance
N/A
N/A
N/A
N/A
11.95
N/A
N/A
N/A
19.44
N/A

BioHarvest Sciences Competition Performance Charts

Five steps to successful analysis of BioHarvest Sciences Competition

BioHarvest Sciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by BioHarvest Sciences in relation to its competition. BioHarvest Sciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of BioHarvest Sciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact BioHarvest Sciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to BioHarvest Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your BioHarvest Sciences position

In addition to having BioHarvest Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Equity ETFs Thematic Idea Now

Broad Equity ETFs
Broad Equity ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 537 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for BioHarvest OTC Stock Analysis

When running BioHarvest Sciences' price analysis, check to measure BioHarvest Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioHarvest Sciences is operating at the current time. Most of BioHarvest Sciences' value examination focuses on studying past and present price action to predict the probability of BioHarvest Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioHarvest Sciences' price. Additionally, you may evaluate how the addition of BioHarvest Sciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY